Physical Activity Levels of Parents of Children With Cystic Fibrosis- (PHACTS-CF)
PHACTS-CF
Investigating Physical Activity Levels of Parents of Children With Cystic Fibrosis and Its Influence on Their Children's Physical Activity Levels and Nebuliser Use
1 other identifier
observational
30
0 countries
N/A
Brief Summary
This study will investigate if parental physical activity levels, assessed by providing a physical activity questionnaire to parents of children aged 6-16 with Cystic Fibrosis (CF), is associated with their child with CF's physical activity levels. Children's activity levels will be taken from electronic records where a questionnaire is routinely given at annual reviews to analyse this. Parental activity levels will also be compared against adherence to nebulisers as a proxy for adherence to treatment, this data is again in the electronic records of patients and is collected at annual reviews.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for all trials
Started Oct 2022
Shorter than P25 for all trials
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
August 4, 2022
CompletedFirst Posted
Study publicly available on registry
August 9, 2022
CompletedStudy Start
First participant enrolled
October 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2023
CompletedAugust 9, 2022
August 1, 2022
1 year
August 4, 2022
August 5, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
GPAQ
Activity questionnaire for parents
Reviews the past 7 days activities.
Secondary Outcomes (4)
CPAQ
Reviews the past 7 days activities.
YPAQ
Reviews the past 7 days activities.
Ineb adherence
1 year
Lung function
Best score in the last 1 year.
Interventions
No intervention will be provided, this is an observational study
Eligibility Criteria
Parents of children with cystic fibrosis.
You may qualify if:
- Parents of Children aged 5-16 years.
- Under the care of Cambridge University Hospitals CF team
- Confirmed Cystic Fibrosis diagnosis
- Uses an ineb as main nebulizer delivery device.
- Parental/guardian permission (informed consent) and if appropriate, child assent.
You may not qualify if:
- Parents of CYP diagnosed with a CF screen positive inconclusive diagnosis (SPID).
- If not yet doing lung function.
- If has any other self-identified physical disability which may limit physical activity.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Central Study Contacts
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
August 4, 2022
First Posted
August 9, 2022
Study Start
October 1, 2022
Primary Completion
October 1, 2023
Study Completion
October 1, 2023
Last Updated
August 9, 2022
Record last verified: 2022-08
Data Sharing
- IPD Sharing
- Will not share
Individual participant data will not be shared.